Sugi Predict

Sugi Predict / Compounds / SCHEMBL10021054

SCHEMBL10021054

SCHEMBL10021054

c1ccc(-c2ccc(-c3ccc(-c4c5ccccc5c5c6c(cccc46)-c4c(-c6ccccn6)ccc(-c6ccccn6)c4-5)cc3)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.38
▸ TP53 P04637 4/20 0.38
▸ SMN1; SMN2 Q16637 4/20 0.38
▸ LMNA P02545 3/20 0.38
▸ HSD17B10 Q99714 3/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ MAPT P10636 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ TSHR P16473 2/20 0.38
▸ PKM P14618 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ BRD4 O60885 1/20 0.38
▸ KLF5 Q13887 1/20 0.38
▸ GRM5 P41594 3/20 0.36
▸ TGFBR1 P36897 2/20 0.35
▸ MAPK1 P28482 3/20 0.35
▸ NPC1 O15118 2/20 0.35
▸ CCR1 P32246 2/20 0.35
▸ CCR5 P51681 2/20 0.35
▸ CCR8 P51685 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL762129 0.88 BRD4 (0.35) KDM4ETP53SMN1; SMN2LMNAHSD17B10
SCHEMBL10021050 0.82 KMT2A (0.46) KDM4EHSD17B10ALDH1A1MAPTHPGD
SCHEMBL17227632 0.81 KDM4E (0.43) KDM4ETP53SMN1; SMN2LMNAHSD17B10
SCHEMBL12032294 0.79 LMNA (0.42) KDM4ETP53SMN1; SMN2LMNAHSD17B10
SCHEMBL18272726 0.79 KDM4E (0.45) KDM4ETP53SMN1; SMN2LMNAHSD17B10
SCHEMBL11992123 0.77 LMNA (0.46) KDM4ETP53SMN1; SMN2LMNAHSD17B10
SCHEMBL17320829 0.77 KDM4E (0.50) KDM4ETP53SMN1; SMN2LMNAHSD17B10
SCHEMBL12655787 0.77 KDM4E (0.54) KDM4ETP53SMN1; SMN2LMNAHSD17B10
SCHEMBL12269907 0.76 PDK2 (0.36) KDM4ETP53SMN1; SMN2LMNAHSD17B10
SCHEMBL30021950 0.76 GRM5 (0.42) KDM4ETP53SMN1; SMN2LMNAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8110824-B2 Benzo[a]fluoranthene compound and organic light emitting device using the same CANON KABUSHIKI KAISHA (JP) 2012-02-07 — — US disclosed
US-8110824-B2 Benzo[a]fluoranthene compound and organic light emitting device using the same CANON KABUSHIKI KAISHA (JP) 2012-02-07 — — US disclosed
US-20110049479-A1 BENZO[a]FLUORANTHENE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME CANON KABUSHIKI KAISHA (JP) 2011-03-03 — — US disclosed
US-20110049479-A1 BENZO[a]FLUORANTHENE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME CANON KABUSHIKI KAISHA (JP) 2011-03-03 — — US disclosed
WO-2008140132-A1 BENZO[A]FLUORANTHENE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME CANON KABUSHIKI KAISHA (JP) 2008-11-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110049479-A1 BENZO[a]FLUORANTHENE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME AFF1, CYP1A1, CYP1B1 KDM4E 3076/4885TP53 3091/4885SMN1; SMN2 1068/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.